• ¥ÍÂå²£·~±Nªï¨Ó¤jªi¬q¦æ±¡  ¶À¤¯¾±±ÈÂåÀø¢Ï¢×¨g¼é¡B¦A¥ÍÂåÀøªk¤TŪ¥ßªk³q¹L
  •   
¡@¡@¡@¡@¡@¡@
§@ªÌ¡G®}¥É§g     ¤å³¹¥X³B¡G¥ý±´Âø»x   2303´Á      ¥X¥Z°Ï¶¡¡G113/06/07~113/06/13


¥¼¨Ó¥Í¬¡±NÂ÷¤£¶}¢Ï¢×¡A¶À¤¯¾±ªººt»¡¦¨¬°¢Ï¢×µo®iÁͶժº¸t¸g¡A¦ÓÂåÀø²£·~§Q¥Î¢Ï¢×¦¨´Nºë·Çªº³t«×Áö¤´»·»·¤£¤Î¡AµM¦ÓªÑ»ù¥Ã»·¨«¦b¨Æ¹êµo¥Í«e¡A¦]¦¹¬ÛÃöªºÂåÀø¢Ï¢×·§©ÀªÑ¤]¦bªñ´Á¦¨¬°¥«³õÃöª`ªºµJÂI¡F¦AªÌ¡A¦A¥ÍÂåÀøÂùªkªGµM¤£­t²³±æ¡A©ó¤W¥b¦~§¹¦¨¤TŪ¥ßªk¡A¬ÛÃöªº²Ó­M»s³y¡B²Ó­M·sÃÄ·~ªÌ¡A¤]±N¨ü´f¥¼¨Ó¦A¥ÍÂåÀøªº½´«kµo®i¦Ó¦¨¬°µJÂI¡C°ê¤º¥Í§ÞÂåÀø²£·~¬J¬O¬Fµ¦±À°Êªº¤U¤@­Ó¥ü¤¸²£·~¡A¨º»ò¦b¥«³õ¸êª÷¤´µM¥R¨K¡B¥Í§Þ§Þ³Nµo®i«ùÄòºë¶i¤U¡A¥ÍÂå±Ú¸s±Nªï¨Ó¤U¤@­Ó¤jªi¬q¦æ±¡¡C

¥ý±q¡u¦A¥ÍÂåÀøªk¡v½Í°_¡A³o­Ó¾ú¸g¤Q¦~ªº°Q½×¡B¤T­Ó·|´Áªº¨ó°Ó¡A²×©ó¦b¤µ¦~¤»¤ë¥|¤é©çªO¤TŪ³q¹L¡A¥ý«e¸Ó®×¨ó°Ó®Éªº´X¶µª§½×ÂI¡A¥]¬A¬O§_¶i¦æ¤HÅé¸ÕÅç¡B¬O§_¯ÇºÞ²§ºØ²Ó­M¡B­L¨àÅv¯q§âÃö¥H¤ÎÂåÀø¾÷ºc¦¨¥ßÀç§Q¾÷ºcªº§Q¯q°jÁ×°ÝÃD¡C³Ì²×¡A¤TŪ±ø¤å±Æ°£­L¨à¡A©ú­q¦A¥ÍÂåÀø²Õ´¡B²Ó­M¨Ó·½ªº´£¨ÑªÌ¡A¥H¦³·NÃѯà¤Oªº¦¨¦~¤H¬°­­¡A¥B¶È¯à©óÂåÀø¾÷ºc°õ¦æ¡F¦¹¥~¡A°£¯S®í±¡§Î¥~(®¦·OÀøªk)¡A°õ¦æ¦A¥ÍÂåÀø³£¶·§¹¦¨¤HÅé¸ÕÅç¡A¥]§t¦A¥ÍÂåÀø½dÃ¥¡B²Õ´²Ó­M¨Ó·½ºÞ²z¡B¤HÅé¸ÕÅç»P¬ã¨s¤ÎºÊ·þ©M¹w¨¾µ¥¡C



¥Íª«¢Ñ¢Ò¢Û¢Ý°Ó¾÷¥¿¦¡°_­¸



¨ü´f¦A¥ÍÂåÀøªkªº¤TŪ³q¹L¡A°ê¤º¬ÛÃö²Ó­MªvÀø¬ÛÃö­ÓªÑ(¸Ô¨£¹Ïªí)§¡¦³¾÷·|¨ü´f¡A¦Ó°£¤F¯SºÞªk¬ÛÃöªº²Ó­M»s³Æ·~ªÌ¥~¡A²Ó­M·sÃĬãµo¯S§O¬OCAR-TÀøªk¦b¬ã¨sªvÀø¨ä¥L¯e¯f¦p¹êÅé½F¡B¦Û¨­§K¬Ì©Ê¯e¯f¡B·P¬V©Ê¯e¯fµ¥§¡¦³¤@©wªºÀ³¥Î«e´º¡AÃD§÷­±§óÂ×´I¡C·í¤¤ªº¨Kº¸¥ÍÂå(6949)°£¤F¾Ö¦³¯SºÞªkªk®Ö­ã³q¹Lªº¥]§t²Ó­M¿E¯À»¤¾É±þ¤â²Ó­M(CIK)¡B¾ð¬ð²Ó­M-²Ó­M¿E¯À»¤¾É±þ¤â²Ó­M(DC-CIK)¡B¤Î¯×ªÕ·F²Ó­M(ADSC)µ¥»s³Æ¥~¡F§ó¬OCAR-TªvÀø»â°ìªº»â¥ýªÌ¡A¾Ö¦³¦Û¥D¶}µoªºCAR³]­p¥­¥x¡A¥B»sµ{¾Ö¦³µu¤Ñ´Á(¤C¤Ñ)¤Î²£¥X°ªTscm¤ñ¨ÒCAR-TªºÀu¶Õ¡A§ó¾Ö¦³¤W´å­ì®Æ¯f¬r¸üÅé(¢Ú¢ä)ªº»s³y¯à¤O¡A¥i¿×¾Ö¦³¤@±øÀsªº¦Û¥D»s³y¥Í²£·s¤@¥Nªº¦hÃìCAR-T¯à¤O¡F¥Ø«eºX¤UªvÀø²O¤ÚÀùªº¤HÅéÁ{§É¥¿¶i¦æ¦Ü²Ä¤G´Á¡A¹w®Æ¤G¤»¦~¯à¦³µ²ªG¡C¦¹¥~¡A¤l¤½¥q¥xÆW²Ó­M»s³y¤½¥q¥¿Äw«Ø¦ì©ó¦Ë¥_¥ÍÂå¶é°Ïªº²Ó­M°ò¦]ÃÄ«~PIC/S GMP¼t©Ð¡A­±¿n¤@¤d©W¡A·m­¹¦A¥ÍÂåÀø°Ó¾÷¡C



¨Kº¸¡B¥Ã©ý¡B¥xÄ_¥ÍÂå¾Ö§Q°ò



¥t¤@®a²Ó­MªvÀø·~ªÌ¥xÄ_¥ÍÂå(6892)¡AºX¤U²Ó­MªvÀø¼t¤é«e³q¹L¢â¢Ô¢Ò¢Ï¬d®Ö¡A¨ú±oPIC/S GMP¥ý¾É¤u¼t»{ÃÒ¡A¦¨¬°°ê¤º²Ä¤@®a³q¹L²§Å鶡¸­·F²Ó­M·sÃÄ¢Õ¢Û¢Þ¼f¬dªº·~ªÌ¡AÅã¥Ü¤½¥qªº¥Í²£¹ê¤O¡C¥Ñ©ó¡A¬ü°ê¥Íª«¦w¥þªk®×³q¹L¦b§Y¡A»P¤¤°ê¬ÛÃöªº¢Ñ¢Ò¢Û¢Ý¼t°Ó±N³v¨B°h¥X¥þ²y³Ì¤jªº¬ü°êÂåÃÄ¥«³õ¡AªÅ¥X¹O¤d»õ²Ó­MÂåÀø¢Ñ¢Ò¢Û¢Ý¨ÑÀ³Ãì¾÷·|¡C¥xÄ_¥¬§½¬ü°ê¥«³õ¦h¦~¡A¤wªì¨B«Ø¥ßª¾¦W«×¡A¦p¤µÀò¢Õ¢Û¢Þ¬d®Ö³q¹L¡A§ó¾A³{·m¥e¬ü°ê²Ó­MÂåÀø¢Ñ¢Ò¢Û¢Ý¥«³õªº¦n®É¾÷¡A¥H§Þ³N»â¥ýªºÀËÅç»P»sµ{¶}µo¶q¯à¡A¯àº¡¨¬¦­´Á²Ó­MªvÀø¶q¯àªº¯Ê¤f¡C

¥Ø«e¥xÄ_¥ÍÂåÀò±oPIC/S GMP»{ÃÒªº²§Åé°©Å趡¸­·F²Ó­MChondrochymal¡A¾AÀ³¯g¬°ªvÀø°h¤Æ©ÊÃö¸`ª¢¡A¤w§¹¦¨¤G´ÁÁ{§É¸ÕÅ禬®×¡A¥¿¶i¦æ¬ÛÃö¸ê®Æªº¾ã²z¤ÀªR¡A¨Ã­pµe¦V¢â¢Ô¢Ò¢Ï¥Ó½Ð¤T´ÁÁ{§É¸ÕÅç³\¥i¡C±q¥xÄ_¥ÍÂåÀç¹B·§ªp¨Ó¬Ý¡A¤µ¦~«e¥|¤ëÀ禬¤w¹F¤@¤C¤C¤T¸U¤¸¡A¦~¼W¤K¤T¡D¤@¥|¢H¡A¤£¶È³Ð¾ú¥v¦P´Á·s°ª¡A¤]¶W¶V¥h¦~¤W¥b¦~À禬Á`©M¤@¤G¤T¤E¸U¤¸¡A¦p¤µ¥¿¦¡³q¹L¢Õ¢Û¢Þ»{ÃÒ¡A¥¿¦¡·m­¹Ãe¤j²Ó­MªvÀø¢Ñ¢Ò¢Û¢Ý·~°È¡AÀç¹B¶i¤J¤jÃzµo´Á¡C

¤@¤E¦~Â૬¬°±M·~¥Í²£¥Íª«ÃĪº¢Ñ¢Ò¢Û¢Ý¤½¥q¥Ã©ý(4726)¡A¥Ø«e«È¤á²[»\°ê¤º¡B¤é¥»¤ÎÁú°ê¡AÁ`±µ®×¼Æ¤wªñ¤­¡³­Ó¡A¨ä¤¤¤T­Ó¤w©ó¤T´ÁÁ{§É¤¤¡A¤@­Ó±M®×¤w¥Ó½ÐÃÄÃÒ¡A¥t¤@­Ó±M®×§Y±N¥Ó½ÐÃÄÃÒ¡C¥Ñ©ó¤½¥qºX¤U¾Ö¦³¨â­Ó¢Õ¢Û¢Þ¼t¡A¨ä¤¤¤@¼t¦³¦h±ø¥Í²£½u¡A¥i¶i¦æ¤Ö¶q¡B¦h¼Ë¡B¼u©Ê¤Æ¥Í²£¡A´£¨ÑÁ{§É«e´Á©Ò»Ý¤§²£¯à¡F¤G¼t«h¥i³W¼Ò¤Æ¤j¶q¥Í²£¡A¥i»Î±µÁ{§É±ß´Á¦Ü¤W¥«ÃÄ«~©Ò»Ýªº¶q²£³W¼Ò¡A¥¼¨ÓÀç¹B¥i´Á¡C

¥t¤@®a¤]³Qµø¬°¦A¥ÍÂåÀø¬Éªº¢Ñ¢Ò¢Û¢Ý°ê®a¶¤¼Ö­{¦A¥Í(6891)¡A¤é«e»P·s¥[©YMediSix Therapeutics Pte. Ltd(¬ü­}¦è´µ¤½¥q)Á|¦æ¦X§@ñ¬ù»ö¦¡¡AMedisix©Ò¥D¾Éªº¥HCD7¼Ð¹vªºCAR-T²£«~¥H¤Î¥i±±¨î³J¥Õªí²{ªºPEBL±M§Q¡A±N»P¼Ö­{¦@¦P¦X§@¶i¦æMedisixªºCAR-T ²Ó­M»s³y»PÁ{§É¸ÕÅç¡AÂù¤è¤]±N¦X§@¦b¥xÆW«Ø¥ß¥þ²yÁ{§É¬ãµo¤¤¤ß¡AÅý¼Ö­{´Â¦¨¬°¨È¬wCAR-T¬ãµo»P»s³y¤è¦VÁÚ¶i¡C

¦^¨ìComputex®i¡A¶À¤¯¾±¦A«×¤ÞÃzªº¢Ï¢×­·¼é¡A¾¨ºÞ¢Ï¢×À³¥Î¦bÂåÀø»â°ìªº¹ê¨Ò¤´¤£ºâ¦h¡A¦ý¬OÀHµÛ¬ÛÃöªº»²§U³nÅéÅý¢Ï¢×¾Ç²ß§ó¬°ºë¶i¡A¢Ï¢×¥iµ²¦X¤j¶qÁ{§É¼Æ¾Ú»P§Y®É¤ÀªR¬ãµoªº¨t²Î¡A´£¨Ñ¹Ï¥Ü¤Æ¤Î¨t²Î¤Æ³ø§i¨ÑÂå®v°Ñ¦Ò¡A»²§U¨äµu®É¶¡¤º²Î¾ã¯f¤H¸ê°T¡Bºë·Ç§PÂ_¯f¯gµ¥¡A¤×¨äÀ³¥Î¦bÂåÀø¼v¹³ªº¼Æ¾Ú§PŪ·U¨Ó·U§Ö³t¥Bºë·Ç¡A¦¹¥~¡A¥ç¯àªø´Á¨ó§UºÞ²z»P°lÂܯf¤Hª¬ªp¡Aµ²¦X¨C¤éªº¥Í²z¼Æ¾Ú¹ê²{¹w¨¾Âå¾Ç¡C



Âå´­¡B®Ê¥°Àç¹B¥i´Á



¨ü´f¢Ï¢×ªºÀ³¥Î´¶¤Î¡A°ê¤º¦bÂåÀø¢Ï¢×»â°ì¯Ñ¯Ð¦³¦¨ªº¦p§»ùÖ´¼Âå(6857)¡Bܦ³Õ(4106)¡Bà±½n(4153)¡B°TÁp°ò¦](4160)¡B¦w§J(4188)¡B©ú¹FÂå(6527)¡BÂå´­(6569)¡B®Ê¥°(6796)¡Bªø¨Î´¼¯à(6841)¡B²±¥°(8403)¡B°Ó¤§¾¹(8409)µ¥¡A§¡¦³¤£¿ùªºµo®iªÅ¶¡¡C¨ä¤¤Âå´­¨­¬°¥þ²y»â¥ýÂåÀø¯Å¸ê°TÀË´ú³]³Æ¨ÑÀ³°Ó¡A§ó¦bÂåÀø¢Ï¢×»â°ì²`¯Ñ¼Ú¬üÂåÀø³]³Æ¥«³õ¦h¦~¡A¥[¤W¬OIntel¡BNvidiaµ¥°ê»Ú¤j¼t¶i¤JÂåÀø¢Ï¢×ªº­º­n¦X§@¹Ù¦ñ¡A¹ï©ó¥þ²yÂåÀø¢Ï¢×¹ï©óÃìµ²°ª¶¥ÂåÀø³]³Æ»PIoTªº»Ý¨D«ùÄò¦¨ªø¡A¨Ï±oÂå´­¦b¥þ²yÂåÀø¢Ï¢×À³¥Î¥«¥e²v³v¦~í°·Ãk¤É¡C¦¹¥~¡A¤½¥q©ó¤µ¦~¤T¤ë¥¬§½¥xÆW·L¥Íª«ÀËÅç«~µP°Ó±Ò·s¥Í§Þ¡A§ë¤J¦A¥ÍÂå¾Ç²£·~¨ÑÀ³Ãì¡A©ó¦A¥ÍÂåÀøÂùªk¤TŪ³q¹L«á¡A¦A¬°Àç¹B¦¨ªø²K§Q°ò¡A¥i«ùÄòÃöª`¡C

®Ê¥°¥H¦Û¥D¶}µo³Ð·sÂåÀø¾¹§÷¨£ªø¡A´x´¤©ß±ó¦¡¤ºµøÃ誺·L«¬ÃèÀY¼v¹³·P´ú¼Ò²Õ©M«Ê¸ËªºÃöÁä§Þ³N¡A§ó¬O°ê¤ºÂå§÷¨ÑÀ³Ã줤¡A²£«~¾î¸ó¼Æ¦ìÂåÀø¡B»·¶ZÂåÀø¡B¨ìÂåÀø¢Ï¢×»â°ìªº¤½¥q¡A²£«~¥]¬Aµøºô½¤¢Ï¢×»²§U¶EÂ_³nÅé¡B³n¦¡¹q¤l»ó«|³ïÃèEES 100¡B¥þ¦Û°Ê²´À£­pµ¥¡Aªñ¦~¿n·¥¯Ñ¯Ð°ª¶¥ÂåÀø¯Ó§÷¥«³õ¡A¨ä¤¤©ß±ó¦¡»H¯ÖÃè¡A°£³q¹L¬üFDA 510(k)¼f¬d®Ö­ã¥~¡A¥ç¥¿¦¡±ÂÅv°ê»Úª¾¦WÂå§÷¤j¼tªi¤h¹y¬ì¾ÇBoston Scientific(°Ó«~¦WVersaVue)¶i¦æ¥þ²y¿W®a¾P°â¡AÅ㨣¨ä«p¹êªº¶}µo»s³y¯à¤O¡A¥i«ùÄòÃöª`¡C

  °]ª÷¼v­µ

§ó¦h



270*90
270*90
270*90
270*90
270*90

270*90
270*90